Mega Lifesciences PCL (BKK:MEGA)

Market Cap	27.25B
Revenue (ttm)	14.32B
Net Income (ttm)	1.86B
Shares Out	871.87M
EPS (ttm)	2.13
PE Ratio	14.68
Forward PE	12.85
Dividend	1.60 (5.16%)
Ex-Dividend Date	Mar 7, 2025

Volume	992,233
Average Volume	1,156,928
Open	30.75
Previous Close	31.00
Day's Range	30.50 - 31.25
52-Week Range	24.30 - 41.25
Beta	0.27
RSI	70.09
Earnings Date	Aug 14, 2025

About Mega Lifesciences PCL

Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods in Southeast Asia and Sub-Saharan Africa. The company operates in three segments: Brands, Distribution, and Original Equipment Manufacture (OEM). It provides various medicines for allergies; blood circulation and memory; bone and joint; liver and digestive; diabetics; eyes, heart, and skin care; pain, sl...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1982
• Employees: 900
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: MEGA

Financial Performance

In 2024, Mega Lifesciences PCL's revenue was 15.39 billion, a decrease of -2.10% compared to the previous year's 15.72 billion. Earnings were 2.01 billion, an increase of 0.99%.